Jorge A. Alfaro-Murillo; Alyssa S. Parpia; Meagan C. Fitzpatrick; Jules A. Tamagnan; Jan Medlock; Martial L. Ndeffo-Mbah; Durland Fish; María L. Ávila-Agüero; Rodrigo Marín; Albert I. Ko; Alison P. Galvani, A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control…
“ To incorporate indirect medical costs and other expenses, our tool allows the user to specify the per-case cost of microcephaly and GBS. The output of our tool includes the combinations of cost and Zika infections averted for which intervention expenditure would be deemed as very cost-effective, cost-effective, or neither. Hover text displays exact values for the intervention cost, DALYs averted, and net health benefit. As information arises, our web-based tool can be adjusted to provide real-time projections of the health burden of the Zika outbreak in different countries. ”
